U.S. Long-Acting Naltrexone Implant Research Advances in 2026 as Two Investigational Programs Remain in Active Clinical Development
Published first-in-human data and two recruiting U.S. Phase 1 studies show continued development of implantable naltrexone, while long-acting naltrexone implants remain investigational in the United States.